Role of endothelin in microvascular dysfunction following percutaneous coronary intervention for nonST elevation myocardial infarction
Phase of Trial: Phase II
Latest Information Update: 14 Jun 2012
At a glance
- Drugs PMZ-2123 (Primary)
- Indications Myocardial infarction
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 14 Jun 2012 Actual patient number is 24 according to ClinicalTrials.gov.
- 14 Jun 2012 Actual end date (Jan 2012) added as reported by ClinicalTrials.gov.